Cyber security for pharmaceuticals is essential in protecting sensitive research, patient data, and intellectual property from cyber threats.
The pharmaceutical industry plays a vital role in global health, from discovering and developing to producing and marketing medications. This sector addresses a wide range of health issues, from minor ailments like the common cold to life-threatening diseases such as cancer. Pharmaceutical manufacturers face immense pressure to innovate and conduct research to develop effective treatments and vaccines.
Cyber Security Threats in the Pharma Industry
A study conducted by Deloitte found that the pharmaceutical industry is becoming the number one target for cybercriminals worldwide. Due to the nature of the industry’s work, the type of information and data obtained by pharma is extremely valuable and, as such, highly appealing to bad actors. It is not only financially motivated criminals that target the industry—state-sponsored groups are the most common perpetrators, aiming to steal data to gain a competitive advantage.
In an industry where innovation takes years and costs millions of dollars, cyber security for pharmaceuticals is critical to preventing intellectual property theft and protecting competitive advantages.
Improve your Cyber Security posture with Sepio’s Solution
Many times, enterprises’ IT and security teams struggle in providing complete and accurate visibility into their hardware assets, especially in today’s extremely challenging IT/OT/IoT environment. This is because there is often a lack of visibility, and physical layer security, which leads to a weakened policy enforcement of hardware access. This may result in security accidents, such as ransomware attacks, data leakage, etc.
Without full visibility into connected devices, cyber security for pharmaceuticals remains incomplete, leaving organizations vulnerable to undetected threats.
In order to address this challenge, ultimate visibility into your hardware assets is required, regardless of their characteristics and the interface used for connection as attackers. Moreover, it is important to be practical and adjust to the dynamic cybersecurity defenses put in place to block them, as well as take advantage of the “blind” spots – mainly through USB Human Interface Device (HID) emulating devices or Physical layer network implants.
In addition to the deep visibility layer, a comprehensive policy enforcement mechanism recommends on best practice policy and allows the administrator to define a strict, or more granular, set of rules for the system to enforce.
Why Choose Sepio for Cyber Security?
Sepio is the leader in the Rogue Device Mitigation (RDM) market and is disrupting the cybersecurity industry by uncovering hidden hardware attacks operating over network and USB interfaces. Sepio’s solution, identifies, detects and handles all peripherals; no device goes unmanaged.
Sepio’s cutting-edge technology enhances cyber security for pharmaceuticals by leveraging Physical Layer fingerprinting, a unique approach to detecting rogue devices.
As the only company in the world to undertake Physical Layer fingerprinting, Sepio calculates a digital fingerprint using device descriptors from all connected peripherals. It then compares these fingerprints against a database of known malicious devices, automatically blocking any potential attacks.
With Machine Learning, the software analyzes device behavior to identify abnormalities—such as a mouse acting as a keyboard—helping to strengthen cyber security for pharmaceuticals by preventing sophisticated cyber threats before they can cause damage.
Ready to Strengthen Your Cyber Security for Pharmaceuticals?
Protect your critical assets, safeguard sensitive data, and stay ahead of cyber threats with Sepio’s cutting-edge solutions. Let us help you enhance your cybersecurity posture and ensure the safety of your pharmaceutical operations. Schedule a personalized demo today to see how Sepio can work for you! Schedule a Demo.
